Literature DB >> 3170431

Limitation of maximal O2 uptake and performance by acute hypoxia in dog muscle in situ.

M C Hogan1, J Roca, P D Wagner, J B West.   

Abstract

The factors that determine maximal O2 uptake (VO2max) and muscle performance during severe, acute hypoxemia were studied in isolated, in situ dog gastrocnemius muscle. Our hypothesis that VO2max is limited by O2 diffusion in muscle predicts that decreases in VO2max, caused by hypoxemia, will be accompanied by proportional decreases in muscle effluent venous PO2 (PvO2). By altering the fraction of inspired O2, four levels of arterial PO2 (PaO2) [21 +/- 2, 28 +/- 1, 44 +/- 1, and 80 +/- 2 (SE) Torr] were induced in each of eight dogs. Muscle arterial and venous circulation was isolated and arterial pressure held constant by pump perfusion. Each muscle worked maximally (3 min at 5-6 Hz, isometric twitches) at each PaO2. Arterial and venous samples were taken to measure lactate, [H+], PO2, PCO2, and muscle VO2. Muscle biopsies were taken to measure [H+] (homogenate method) and lactate. VO2max decreased with PaO2 and was linearly (R = 0.99) related to both PVO2 and O2 delivery. As PaO2 fell, fatigue increased while muscle lactate and [H+] increased. Lactate release from the muscle did not change with PaO2. This suggests a barrier to lactate efflux from muscle and a possible cause of the greater fatigue seen in hypoxemia. The gas exchange data are consistent with the hypothesis that VO2max is limited by peripheral tissue diffusion of O2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170431     DOI: 10.1152/jappl.1988.65.2.815

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  11 in total

Review 1.  Central and peripheral aspects of oxygen transport and adaptations with exercise.

Authors:  P D Wagner
Journal:  Sports Med       Date:  1991-03       Impact factor: 11.136

Review 2.  A comparative meta-analysis of maximal aerobic metabolism of vertebrates: implications for respiratory and cardiovascular limits to gas exchange.

Authors:  Stanley S Hillman; Thomas V Hancock; Michael S Hedrick
Journal:  J Comp Physiol B       Date:  2012-07-10       Impact factor: 2.200

Review 3.  Mitochondrial function at extreme high altitude.

Authors:  Andrew J Murray; James A Horscroft
Journal:  J Physiol       Date:  2015-06-26       Impact factor: 5.182

4.  The effects of aerobic exercise on skeletal muscle metabolism, morphology and in situ endurance in diabetic rats.

Authors:  Nilay Ergen; Hatice Kurdak; Seref Erdogan; Ufuk Ozgü Mete; Mehmet Kaya; Nurten Dikmen; Ayşe Doğan; Sanli Sadi Kurdak
Journal:  J Sports Sci Med       Date:  2005-12-01       Impact factor: 2.988

5.  The mechanical effects of contractions on blood flow to the muscle.

Authors:  R Naamani; S N Hussain; S Magder
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

Review 6.  The effect of carbon monoxide on respiration.

Authors:  P Haab
Journal:  Experientia       Date:  1990-12-01

7.  Pretreatment with a soluble activin type IIB receptor/Fc fusion protein improves hypoxia-induced muscle dysfunction.

Authors:  Emidio E Pistilli; Sasha Bogdanovich; Matias Mosqueira; Jennifer Lachey; Jasbir Seehra; Tejvir S Khurana
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-10-28       Impact factor: 3.619

8.  Determinants of maximal oxygen uptake in moderate acute hypoxia in endurance athletes.

Authors:  Pascal Mollard; Xavier Woorons; Muriel Letournel; Christine Lamberto; Fabrice Favret; Aurélien Pichon; Michèle Beaudry; Jean-Paul Richalet
Journal:  Eur J Appl Physiol       Date:  2007-05-30       Impact factor: 3.078

9.  Oxidative capacity interacts with oxygen delivery to determine maximal O(2) uptake in rat skeletal muscles in situ.

Authors:  Russell T Hepple; Jason L Hagen; Dan J Krause
Journal:  J Physiol       Date:  2002-06-15       Impact factor: 5.182

10.  The role of oxygen in determining phosphocreatine onset kinetics in exercising humans.

Authors:  Luke J Haseler; Casey A Kindig; Russell S Richardson; Michael C Hogan
Journal:  J Physiol       Date:  2004-05-28       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.